Edition:
United Kingdom

UCB FY Net Sales Went Up By 5% To 4.41 Billion Euros


Thursday, 28 Feb 2019 

Feb 28 (Reuters) - UCB SA ::FY REVENUE REACHED € 4.6 BILLION: +2%, +5% CER1; NET SALES INCREASED TO € 4.4 BILLION: +5%, +8% CER, DRIVEN BY CORE PRODUCTS (+6%, +10% CER).FINANCIAL OUTLOOK FOR 2019: REVENUE EXPECTED IN THE RANGE OF € 4.6 - 4.7 BILLION.OUTLOOK 2019 RECURRING EBITDA2 IN THE RANGE OF 27% - 29% OF REVENUE.FY UNDERLYING PROFITABILITY (REBITDA) INCREASED TO € 1 398 MILLION: 2%, +5% CER.FOR FY, PROPOSES DIVIDEND OF EUR 1.21 PER SHARE (GROSS), +2.5%.FY CIMZIA NET SALES EUR 1.45 BILLION VERSUS EUR 1.42 BILLION YEAR AGO.FY VIMPAT NET SALES EUR 1.1 BILLION VERSUS EUR 976 MILLION YEAR AGO.FY BRIVIACT NET SALES EUR 142 MILLION VERSUS EUR 87 MILLION YEAR AGO.FY NEUPRO NET SALES EUR 321 MILLION VERSUS EUR 314 MILLION YEAR AGO.FY KEPPRA NET SALE EUR 790 MILLION VERSUS EUR 778 MILLION YEAR AGO.FY EBIT EUR 1.10 BILLION VERSUS EUR 1.09 BILLION YEAR AGO.CIMZIA IS EXPECTED TO REACH € 1.7 BILLION BY 2024.VIMPAT SHOULD REACH 1.4 BILLION BY 2022.FY PROFIT EUR 823 MILLION VERSUS EUR 771 MILLION YEAR AGO.